WELCOME

NDC	HCPCS	HCPCS Description	NDC Label	Route of Administration
55150-0191-83	J1740	INJECTION, IBANDRONATE SODIUM, 1 MG	IBANDRONATE SODIUM 1 MG/1 ML	IV
55150-0192-01	J0153	INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)	ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML	IV
55150-0192-20	J0153	INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)	ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML	IV
55150-0193-01	J0153	INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)	ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML	IV
55150-0193-30	J0153	INJECTION, ADENOSINE, 1 MG (NOT TO BE USED TO REPORT ANY ADENOSINE PHOSPHATE COMPOUNDS)	ADENOSINE (SDV,PF,LATEX-FREE) 3 MG/1 ML	IV
55150-0194-10	J1805	INJECTION, ESMOLOL HYDROCHLORIDE, 10 MG	ESMOLOL HCL 10 MG/1 ML	IV
55150-0195-20	J2795	INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG	ROPIVACAINE HCL (SDV,PF,LATEX-FREE) 2 MG/1 ML	IJ
55150-0196-99	J2795	INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG	ROPIVACAINE HCL (SDV,PF,LATEX-FREE) 2 MG/1 ML	IJ
55150-0197-20	J2795	INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG	ROPIVACAINE HCL (SDV,PF,LATEX-FREE) 5 MG/1 ML	IJ
55150-0198-30	J2795	INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG	ROPIVACAINE HCL (SDV,PF,LATEX-FREE) 5 MG/1 ML	IJ
55150-0199-20	J2795	INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG	ROPIVACAINE HCL (SDV,PF,LATEX-FREE) 7.5 MG/1 ML	IJ
55150-0200-10	J2795	INJECTION, ROPIVACAINE HYDROCHLORIDE, 1 MG	ROPIVACAINE HCL (SDV,PF,LATEX-FREE) 10 MG/1 ML	IJ

HCPCS Code	Description	Billing Unit	SA Type
A7005	Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable	Each	N
A7006	Administration set, with small volume filter pneumatic nebulizer	Each	N
A7007	Large voume nebulizer, disposable, unfilled, used with aerosol compressor	Each	N
A7008	Large volume nebulizer, disposable, Prefilled, used with aerosol compressor	Each	N